Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Avery Dennison | AVY | 27. dec 2024 | 188.51 | -0.44 |
Axon Enterprise | AXON | 27. dec 2024 | 610.98 | -2.06 |
Baker Hughes A | BKR | 27. dec 2024 | 40.80 | -0.20 |
Ball | BALL | 27. dec 2024 | 55.83 | -0.64 |
Bank Of America | BAC | 27. dec 2024 | 44.34 | -0.47 |
Bank Of New York Mellon | BK | 27. dec 2024 | 77.57 | -1.00 |
Baxter International | BAX | 27. dec 2024 | 29.20 | -0.34 |
Becton, Dickinson And Co | BDX | 27. dec 2024 | 228.49 | +0.16 |
Berkshire Hathaway B | BRK-B | 27. dec 2024 | 456.51 | -0.56 |
Best Buy | BBY | 27. dec 2024 | 88.03 | -1.50 |
Bio-Techne | TECH | 27. dec 2024 | 72.98 | -0.32 |
Biogen | BIIB | 27. dec 2024 | 151.31 | +0.94 |
BlackRock | BLK | 27. dec 2024 | 1 044.18 | -0.96 |
Blackstone | BX | 27. dec 2024 | 174.01 | -1.39 |
Boeing | BA | 27. dec 2024 | 180.72 | +0.19 |
Booking | BKNG | 27. dec 2024 | 5 037.39 | -1.15 |
BorgWarner | BWA | 27. dec 2024 | 32.19 | -0.22 |
Boston Properties | BXP | 27. dec 2024 | 74.61 | -2.13 |
Boston Scientific | BSX | 27. dec 2024 | 90.66 | -0.86 |
Bristol-Myers Squibb | BMY | 27. dec 2024 | 57.68 | -0.55 |
Broadcom | AVGO | 27. dec 2024 | 241.75 | -1.47 |
Broadridge Financial Solutions | BR | 27. dec 2024 | 226.37 | -0.60 |
Brown & Brown | BRO | 27. dec 2024 | 102.89 | -0.82 |
Brown Forman B | BF-B | 27. dec 2024 | 38.82 | -1.70 |
Builders Firstsource | BLDR | 27. dec 2024 | 145.08 | -2.09 |
Bunge | BG | 27. dec 2024 | 78.07 | +0.01 |
C.H. Robinson Worldwide | CHRW | 27. dec 2024 | 103.89 | -0.41 |
Cadence Design Systems | CDNS | 27. dec 2024 | 305.03 | -1.19 |
Caesars Entertainment | CZR | 27. dec 2024 | 33.09 | -0.72 |
Camden Property Trust | CPT | 27. dec 2024 | 115.23 | -1.01 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.